Lamstein Joshua R 4
4 · Scopus BioPharma Inc. · Filed Jul 27, 2021
Insider Transaction Report
Form 4
Lamstein Joshua R
DirectorChairman
Transactions
- Purchase
Common Stock, par value $0.001
2021-07-23$4.71/sh+1,500$7,065→ 118,797 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.